Browsing by Author Parsons, Michael T

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2014Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that RCA1:c.122A>G(p.His41Arg) is a pathogenic mutationLeary, Jennifer; Dopita, Belinda; Lakhani, Sunil R.; Parsons, Michael T; Thorne, Heather; Tucker, K; Warwick, Linda; Whiley, Phillip J; Western Clinical School: Medicine (Westmead)Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that RCA1:c.122A>G(p.His41Arg) is a pathogenic mutation, PloS One, vol.9, 1, 2014,pp e86836-N/A
2014Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortiaBalleine, Rosemary; Carpenter, Jane; Clarke, Christine; Barrowdale, Daniel; Bolla, Manjeet K; Couch, Fergus J.; Healey, Sue; McGuffog, Lesley; Parsons, Michael T; Schmutzler, Rita Katharina; Spurdle, Amanda B; Wang, Qin; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteRefined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia, Breast Cancer Research, vol.16, 9, 2014,pp 1-16
2014Tumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 Years Optimizes Triage for Population-Level Germline Mismatch Repair Gene Mutation TestingKirk, Judy; Arnold, Sven T; Buchanan, Daniel D; Clendenning, Mark; et al, Various; Ferguson, Kaltin; Lose, Felicity A; Metcalf, Alexander M; Parsons, Michael T; Tan, Yen Y; Thompson, Bryony A; Walsh, Michael; Western Clinical School: Westmead Millennium InstituteTumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 Years Optimizes Triage for Population-Level Germline Mismatch Repair Gene Mutation Testing, Journal of Clinical Oncology, vol.32, 2, 2014,pp 90-100